Preneoplastic stromal cells promote BRCA1-mediated breast tumorigenesis

Nat Genet. 2023 Apr;55(4):595-606. doi: 10.1038/s41588-023-01298-x. Epub 2023 Mar 13.

Abstract

Women with germline BRCA1 mutations (BRCA1+/mut) have increased risk for hereditary breast cancer. Cancer initiation in BRCA1+/mut is associated with premalignant changes in breast epithelium; however, the role of the epithelium-associated stromal niche during BRCA1-driven tumor initiation remains unclear. Here we show that the premalignant stromal niche promotes epithelial proliferation and mutant BRCA1-driven tumorigenesis in trans. Using single-cell RNA sequencing analysis of human preneoplastic BRCA1+/mut and noncarrier breast tissues, we show distinct changes in epithelial homeostasis including increased proliferation and expansion of basal-luminal intermediate progenitor cells. Additionally, BRCA1+/mut stromal cells show increased expression of pro-proliferative paracrine signals. In particular, we identify pre-cancer-associated fibroblasts (pre-CAFs) that produce protumorigenic factors including matrix metalloproteinase 3 (MMP3), which promotes BRCA1-driven tumorigenesis in vivo. Together, our findings demonstrate that precancerous stroma in BRCA1+/mut may elevate breast cancer risk through the promotion of epithelial proliferation and an accumulation of luminal progenitor cells with altered differentiation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • BRCA1 Protein / genetics
  • Breast Neoplasms* / pathology
  • Carcinogenesis / pathology
  • Cell Transformation, Neoplastic / metabolism
  • Female
  • Humans
  • Mammary Glands, Human* / metabolism
  • Mutation
  • Stromal Cells / pathology

Substances

  • BRCA1 Protein
  • BRCA1 protein, human